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Abstract Through the R25 Cancer Education Grants
Program (CEGP), the National Cancer Institute (NCI) has
been supporting the broad educational needs of the cancer
research and cancer healthcare communities since 1974. NCI
sponsored a workshop on September 13, 2016 in Bethesda,
Maryland, with the objectives of sharing best practices in can-
cer education, communicating R25 CEGP programmatic in-
formation, and gathering ideas to strengthen the R25 CEGP to
better meet the emerging needs in cancer education in the face
of a rapidly changing landscape in cancer research and cancer
care. With 53 leaders in cancer education in attendance, the
workshop featured an overview of the R25 CEGP by NCI
Program Staff, a showcase of several types of CEGP programs
by current R25 grantees, and in-depth discussions on a broad
range of questions critical for the continued success of the R25
CEGP. The workshop afforded an opportunity, for the first
time, for cancer researchers and clinicians conducting differ-
ent forms of cancer education activities to gather in one place
as leaders of a community of increasing importance. The dis-
cussion resulted in a set of suggestions that will benefit the
R25 CEGP and cancer education in general. There was a
general consensus among the participants that bringing the
cancer education community together is a significant achieve-
ment of the workshop that will have a long-lasting impact on
cancer education.
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Introduction
The National Institutes of Health (NIH) R25 research educa-
tion program complements research training programs such as
the National Research Service Awards (NRSA) and Career
Development Awards (typically referred as K awards) in de-
veloping the nation’s current and future health research and
healthcare workforce [1]. While the NRSA and K awards
typically provide stipend/salary support to trainees in the early
stages of their research careers for formal research training,
R25 awards are designed to meet the diverse educational
needs of a broad range of participants, including students,
researchers, healthcare providers, and public health profes-
sionals. Typically, R25 awards provide funds to institutions
for developing and implementing education programs that
disseminate scientific discoveries, promote appreciation/
interest in health research, offer hands-on exposure to biomed-
ical research, and develop specific research skills in needed
areas. To meet this broad set of goals, R25 programs make use
of various forms of educational designs and approaches [1].
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NCI began to support the Cancer Education Grants
Program (CEGP) using the R25 funding mechanism in the
wake of the initiation of the National Cancer Program autho-
rized by the National Cancer Act of 1971 [2]. From 1974 to
1993, NCI solicited R25 grant applications for Professional
Oncology Education Programs, Clinical Cancer Education
Programs, and Cancer Education Programs through several
Notices published in the NIH Guide [3–5]. When special ed-
ucational needs arose, NCI also issued R25 Requests for
Applications, e.g., for cancer education programs in painman-
agement [6]. NCI-supported R25 projects during this period
helped educate physicians, students, and patients about cancer
and cancer research, as well as disseminate discoveries in new
areas of cancer research and care. In 1993, NCI published its
first formal R25 CEGP funding opportunity announcement
(FOA) to provide institutions with a Bwide range of opportu-
nities to develop and sustain unique, innovative curriculum-
driven programs that focus on various cancer education
activities^ [7]. In the two decades thereafter, this FOA was
reissued six times to fund the R25 CEGP until 2015 [8].
During this period of time, as cancer research underwent a
rapid expansion in scope, the R25 CEGP evolved concurrent-
ly to support education projects in a wide range of cancer
research fields in the forms of Short-term Education (skills
development) programs, Short-termResearch Experience pro-
grams, and Institutional Curriculum Development projects
[8].1
Since 2015, the R25 CEGP has undergone a transition by
utilizing multiple specialized FOAs each funding a different
form of R25 project. While using a single FOA to support
various forms of educational projects afforded programmatic
flexibility, it also presented a challenge for assessment of these
programs as a whole because of the difficulty in comparing
the merits of projects that differ in their goals, scopes, and
activities. In an effort to enable evaluation of similar forms
of R25 programs using comparable standards, NIH revised the
guidelines for the R25 program to require the use of special-
ized R25 FOAs each supporting education projects involving
the same type of activity(ies). Furthermore, the revised NIH
R25 guidelines require designated FOAs for Programs to
Promote Diversity, which provide funding for R25 programs
focusing on enhancing the workforce diversity in biomedical,
clinical, behavioral, and social sciences. This policy change
led to the publication of five NCI R25 FOAs [9–13], collec-
tively supporting the R25 CEGP previously funded by a sin-
gle FOA [8]. This transition to individual FOAs also led to an
administrative change. The NCI Cancer Training Branch in
the Center for Cancer Training that solely administered the
R25 CEGP in the past now shares this responsibility with
the Diversity Training Branch in the Center to Reduce
Cancer Health Disparities, which manages R25 FOAs for
Programs to Promote Diversity.
The needs to adequately communicate with the cancer ed-
ucation community about the transition the R25 CEGP is cur-
rently undergoing, as well as to gather ideas to strengthen the
program at a time when breakthroughs in cancer research are
achieved at a breath-taking pace, led to NCI’s decision to
sponsor the BNCI Cancer Education Workshop 2016^ on
September 13, 2016 in Bethesda, Maryland (Appendix 1).
Fifty-three leaders in cancer education (Appendix 2), includ-
ing R25 CEGP applicants, principal investigators (PIs), and
peer-reviewers; NIH/NCI staff with leadership roles in the
policy, program, and scientific review of the R25 CEGP;
and representatives from professional organizations with ac-
tive roles in cancer education participated in the workshop.
This report is a summary of the proceedings of the workshop.
Cancer Education Grant Program Overview
In the first session of the workshop, NCI staff provided an
overview of the R25 CEGP. NCI has invested approximately
$13 million in the R25 CEGP in each of the past 5 years. On
average, NCI received 36 competing applications and
awarded 11 new R25 grants per year, for an annual success
rate of 30.5%. At the end of FY 2016, the R25 CEGP portfolio
includes 52 active awards. The impact of the program is far
reaching as these awards support educational activities in a
broad range of cancer research fields benefiting more than
3200 CEGP participants at various career stages every year.
The five active FOAs (Table 1) supporting the R25 CEGP
are: (i) PAR-15-150 (Curriculum or Methods Development),
which supports the development of new curricula, novel in-
structional approaches or tools that are readily adaptable by
the cancer education community; (ii) PAR-15-151 (Courses
for Skills Development), which supports innovative graduate-
level courses that increase the core skills and/or enhance the
motivation of participants to consider a cancer-focused career;
(iii) PAR-15-152 (Research Experiences), which supports in-
novative, hands-on, cancer research experiences to stimulate
interest in further training in cancer research; (iv) PAR-16-138
(Program to Promote Diversity-Research Experiences); and
(v) PAR-16-139 (Program to Promote Diversity-Courses for
Skills Development). The last two FOAs are similar to PAR-
15-152 and PAR-15-151, respectively, but are designated for
participants who are underrepresented in biomedical, clinical,
behavioral, and social sciences. Collectively, these five FOAs
support the activities previously supported by a single FOA
[8]. Each of the current FOAs has specific requirements/
1 NCI also used the R25 funding mechanism to support the Cancer Education
and Career Development Program, often known as the R25T program. This
program has ended and merged into the NRSAT32 Training Grant Program,
as announced in NOT-CA-13-008. In addition, NCI supports an R25 Youth
Enjoy Science Program through PAR-17-059 that engages underrepresented
students from grades 6 through college and their teachers. These R25 pro-
grams, however, are different from the R25 CEGP.
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instructions on issues such as the eligible types of participants,
allowable budget and budget structure, and the duration of the
grants. Table 1 below summarizes the key features of the new
FOAs. Full details can be found in the FOAs [9–13].
Showcase of Currently Funded R25 CEGP Projects
In the next two sessions of the workshop, the PIs of six cur-
rently funded programs each gave a 30-min presentation to
showcase the goals, designs, and accomplishments of their
respective programs. These programs, some long-standing
while others relatively new, feature various types of education
activities that the R25 CEGP supports. Below is a summary of
these presentations.
i. BMethods in Clinical Cancer Research Workshop,^
(R25CA068647, PI: Daniel D. Von Hoff, American
Association for Cancer Research) [14].
This program represents an example of a BCourses for
Skills Development^ type of R25 project. It is an intensive
one-week educational workshop held annually in Vail,
Colorado and partially supported by an R25 CEGP award
since 1996. The goal of the workshop is to teach young in-
vestigators clinical trial design and implementation. Each
summer, 100 early career oncology fellows and junior faculty
participate in the workshop, taught by 50 dedicated faculty
including clinical investigators, biostatisticians, and patient
advocates. Each participant brings to the course a protocol
concept, which he or she develops into an IRB-ready clinical
trial protocol with associated informed consent documents
during the week. A mix of didactic lectures, small group dis-
cussions, and one-on-one mentoring is combined with daily
protocol development group sessions to provide training in the
methods, design, and conduct of clinical trials. Follow-up
questionnaires completed by participants between 1 and
5 years after the workshop are used to measure the impact of
the workshop on the participants’ careers. To date, 2100 par-
ticipants have completed the workshop, which represent a
significant portion of the nation’s research oncologist
community.
ii. BIntegrated course in Biology and Physics of Radiation
Oncology (IBPRO),^ (R25CA171971, PIs: Michael C.
Joiner and Monica Tracey, Wayne State University) [15].
This program is another example of the BCourses for Skills
Development^ type of R25 project. This 5.5-day program in
advanced radiobiology and medical physics is designed to
address the disconnection between the increasing demand
for radiotherapy and the decreasing activity in radiation re-
search. The course is organized around a set of pertinent
themes in radiation oncology and includes both physics- and
biology-oriented, theme-related keynote lectures, as well as
interactive activities, such as a Virtual Hospital, analysis of
radiation oncology protocols, panel discussions, debates of
controversial topics in radiation oncology, and networking
activities. The in-person course is enriched by additional ma-
terials provided online. Approximately 15 faculty members
teach the course each year. Fifty participants are recruited
annually among researchers and clinicians who either work
or are interested in radiation oncology. Each year, at least three
potential new faculty members are invited to participate and
are provided with additional mentoring so that they may con-
tribute to IBPRO in subsequent years and also build their own
local training programs. Since 2013, over 140 individuals
have participated in IBPRO, and their evaluations of the
course have been gathered by surveys.
iii. BA National Curriculum in Cancer Genomics for
Pathology Residents,^ (R25CA168544, PI: Richard L.
Haspel, Beth Israel Deaconess Medical Center) [16–18].
This is a combined BCurriculum Development^ and
BCourses for Skills Development^ R25 project developed by
the national Training Residents in Genomics (TRIG) Working
Group. The objective of the curriculum is to provide patholo-
gists the much needed knowledge and skills required to prac-
tice genomic medicine, focusing on next-generation sequenc-
ing techniques that allow molecular prognostic stratification
of patients and genotype-guided therapy. The curricular re-
source includes readings, lectures, and team-based learning
activities. Since 2013, the curriculum has been deployed in
over 20 national and international workshops and courses,
often held in conjunction with annual meetings of professional
societies. Participants typically include pathology trainees and
practicing pathologists but there have also been Btrain-the-
trainer^ sessions for geneticists. The evaluation of the national
implementation and efficacy of the curriculum is based on
results of the pathology resident in-service exam (RISE),
which all US pathology residents complete as a test of com-
petency. To facilitate dissemination of the curriculum, an in-
structor handbook and toolkit have been developed and
downloaded from the TRIG website by over 450 participants.
Online versions of the learning exercises have also been de-
veloped and are currently being evaluated in 10 residency
programs.
iv. BUAB Cancer Research Experiences for Students,^
(R25CA076023, PIs: John W. Waterbor and Peter
Smith, University of Alabama at Birmingham (UAB))
[19–21].
The BUAB Cancer Research Experiences for Students^
(CaRES) program, supported by an NCI R25 award since
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1999, represents an example of the BResearch Experiences^
type of project. The goal of the program is to motivate partic-
ipants to consider careers in cancer research by providing
them with the opportunity to complete a cancer research pro-
ject under the mentorship of a faculty preceptor that could
result in a publication. CaRES participants include medical,
veterinary, pharmacy, and graduate public health students
from UAB and three other universities in Alabama. Forty
participants complete an 8 to 12-week summer internship at
UAB or the Hudson Alpha (HA) Institute for Biotechnology
in Huntsville, AL. Students use a Bself-matching^ process to
identify best-suited research projects available to them and
complete a mentoring contract with a corresponding faculty
preceptor drawn from approximately 400 UAB faculty mem-
bers. In addition to their research projects, CaRES participants
also propose an Individual Development Plan, attend a semi-
nar series, take part in clinical Bshadowing^ opportunities, and
present their research findings locally at a CaRES forum.
Some students also present their research regionally and na-
tionally, as well as publish the findings with their preceptors.
To date, over 600 students, about 20% of them underrepre-
sented individuals, have participated in CaRES. Longitudinal
tracking of the CaRES graduates from 1999 to 2015 shows
that 15% are actively involved in cancer research and 27%
have published cancer-related, peer-reviewed papers.
v. BCancer Prevention Education: Student Research
Experiences,^ (R25CA056452, PI: Shine Chang,
University of Texas MD Anderson Cancer Center) [22,
23].
The objective of this BResearch Experiences^ project,
supported by an NCI R25 award since 1992, is to en-
courage participants to consider careers in cancer preven-
tion research. Each summer, 25 undergraduate, graduate,
and health professional students are provided with a 10-
week mentored cancer prevention research experience,
along with career development opportunities, seminars,
and other educational activities. Recruitment occurs na-
tionally and through linkages with Texas Medical Center-
affiliated academic institutions. The program emphasizes
the cultivation and support of a pool of over 100 faculty
mentors, and recognizes model mentors. The Program
Leadership and Advisory Committee match prospective
participants with mentors who have submitted descrip-
tions of available research projects. At the conclusion
of the R25 program, participants present their findings
at two formal institutional events. Some participants then
go on to present their research at professional meetings
and publish with their mentors. To date, 364 students,
approximately 29% of them underrepresented individ-
uals, have completed the program. Longitudinal tracking
of students who have participated in the program during
the past 10 years shows that about half have completed
their training, and of those, 53% are involved in research
and 20% work in healthcare.
vi. BÉxito! Latino Cancer Research Leadership Training,^
(R25CA134301, PI: Amelie G Ramirez, University of
Texas Health Science Center at San Antonio) [24].
This combined BCourses for Skill Development^ and
BResearch Experiences^ type of R25 program focuses on
doctoral-level preparation in the social, behavioral, and public
health sciences for Latinos and intends to address the deficit of
public health doctoral degrees awarded to Latinos. The pro-
gram supports a five-day Summer Institute (SI) that is accom-
panied by web-based academic support, career-building oppor-
tunities, interactive online communication forums, and facili-
tated connections to pre- and post-doctoral programs. Each
year, 25 participants are recruited nationally to take part in the
SI, and up to 10 of them may subsequently be awarded a paid
summer internship in Latino cancer control research that is also
supported by the R25 award. Since 2010, 125 participants have
attended an SI and report significantly greater confidence that
they will apply to a doctoral program in the next 5 years, as well
as significantly greater self-efficacy in their ability to be accept-
ed to and succeed in a doctoral program. Of the SI participants
from 2010 to 2015, 30% have applied to doctoral programs and
21% are currently enrolled in doctoral programs with the ma-
jority being interested in pursuing a cancer-related career.
Group Discussions
Following the presentations, participants were assigned to
four breakout groups for concurrent discussions of a set of
broad-themed questions designed to gather ideas from the
cancer education community to strengthen the R25 CEGP.
Discussion leaders of each group then presented the salient
points noted by their respective group to all participants for
a general discussion. A synopsis of the discussion on each
question is as follows:
i. What are the cancer research areas where R25 cancer ed-
ucation programs would make the greatest impact to the
research/clinical workforce? Why?
A consensus high impact area for the R25 CEGP identified
by all four breakout groups was to support cancer education
programs that help bring a basic understanding of break-
throughs in emerging cancer research fields to a broad range
of participants, including students, researchers, healthcare pro-
viders, and public health professionals. Examples of such
emerging fields include cancer immunotherapy, precision
medicine, genome editing/alteration technologies, as well as
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all types of B-omics^ and Bbig data^ science. Given that break-
throughs are being made at an unprecedented pace, R25-
supported education programs offer an ideal means to help
keep the cancer research/care communities updated with the
progress. Another important area recognized was to continue
to support projects that help healthcare providers better meet
the needs of cancer patients as they transition from treatment
to survivorship to palliative care and end of life, because the
formal clinical training provided to healthcare providers in
these areas remains inadequate. Among other suggestions
were that the R25 CEGP should continue to support efforts
to Btrain-the-trainers^ through nurturing current program par-
ticipants for a future faculty role or enhancing the teaching and
mentoring skills of less experienced program faculty mem-
bers; strengthen support for cancer education projects with
international participation and/or learning activities; and en-
courage Research Experiences programs that provide partici-
pants with exposures beyond traditional research areas, such
as community health, healthcare industry, and health policy.
ii. What are the most effective designs or models for R25
cancer education programs? What are their respective
strengths?
Diversifying the R25 CEGP faculty was considered critical
to strengthening the effectiveness of education programs.
Traditionally, faculty members are predominantly academic
researchers with expertise in fields related to the focus of a
given R25 project. It was suggested that R25 education pro-
grams are ideal venues to recruit program faculty from indus-
try, public health communities, patient advocacy organiza-
tions, and cancer patients and caregivers to teach alongside
academic faculty. Such an approach would provide program
participants with real world perspectives as well as exposure
to multidisciplinary approaches and team science.With regard
to new ways for R25 CEGP participants to acquire knowledge
and skills, it was suggested that a team-based case study ap-
proach is highly effective as it offers excellent opportunities
for participants with different backgrounds to learn from each
other. Online and social media resources were recognized as
effective tools for delivering education program content, pro-
viding mentoring, and conducting program evaluation.
Furthermore, it was suggested that R25 education programs
designed to enhance core professional competencies should
consider awarding participants certificates or continuing edu-
cation units (CEUs).
iii. Assuming that you are a member of the Study Section,
what are the aspects of R25 cancer education programs
that you think should be critically evaluated? Why?
R25 applications, like most other types of NIH grant appli-
cations, are evaluated primarily based on five review criteria,
namely, significance, investigator(s), innovation, approach,
and environment. Many participants pointed out that, because
R25 CEGP applications collectively are expansive in scientif-
ic scope, diverse in methodologies, and varied in desired out-
comes, it is crucial for applicants to clearly articulate the
Bsignificance^ of the proposed program. Specifically, it was
suggested that the inclusion of a thorough needs assessment
supported by a literature review in the application is critical in
establishing the Bsignificance^ of the proposed project. It was
also noted that a clear description of appropriate methods and/
or activities with measurable outcomes as benchmarks of suc-
cess is essential for objective evaluation of an application’s
Bapproach^. Furthermore, participants pointed out that diver-
sity recruitment plans must include adequate descriptions of
efforts to address the challenges a given programmay encoun-
ter in recruiting underrepresented individuals, and competing
renewal applications must accurately report the record of their
diversity recruitment efforts during the prior period of grant
support. There was also a very strong desire among workshop
participants that all R25 CEGP applications should be
reviewed appropriately and consistently. To that end, it is im-
portant that reviewers of CEGP applications fully understand
the specific instructions for each review criterion as described
in the FOAs and explained by NCI staff during the pre-review
orientation.
iv. What are the most effective approaches for R25 cancer
education programs, especially R25 Programs to
Promote Diversity, to increase participation of underrep-
resented individuals and enhance workforce diversity?
Reaching out to Minority-Serving Institutions (MSIs) and
professional societies, such as the National Medical
Association (NMA) and the Society for the Advancement of
Chicanos and Native Americans in Science (SACNAS), was
identified as an effective strategy to increase the participation
of underrepresented individuals in R25 cancer education pro-
grams. This strategy may also lead to collaborations between
major academic institutions and MSIs/professional societies
in developing new R25 programs. To this end, a number of
workshop participants urged NCI to help leverage other NCI
Programs to Promote Diversi ty such as the U54
Comprehensive Partnerships to Advance Cancer Health
Equity (CPACHE), supported through PAR-15-103; the P20
Feasibility Studies to Build Collaborative Partnerships in
Cancer Research, supported through PAR-16-084; and the
Geographic Management of Cancer Health Disparities
Program (GMaP) [25] to broaden the pool of underrepresent-
ed individuals for R25 cancer education programs. Another
strategy noted by several participants was to raise the subsis-
tence or salary provided to participants. It was pointed out that
many underrepresented students need to maintain income
streams for their families while participating in R25 cancer
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education programs, and paying a subsistence or salary that is
at least equivalent to the local minimum wage may make it
easier for these students to participate in R25 cancer education
programs. Related to this point, it was suggested that allowing
participation in R25 cancer research experience programs on a
part-time basis might afford these students the flexibility to
meet both their academic goals and personal commitments.
Several other strategies, including recruiting diverse program
faculty to serve as effective role models, demonstrating how
cancer research helped improve health in underrepresented
communities, and showcasing different types of cancer-
related career options, were also considered effective in
recruiting and retaining underrepresented students.
Conclusions/Perspectives for the Future
The workshop succeeded in meeting all its stated objectives.
NCI Program Staff provided an informative overview of the
R25 CEGP, and a detailed explanation of the FOAs that sup-
port the program, which are of critical importance for the
successful transition of the R25 CEGP. PIs of six current
R25 programs, which feature diverse forms of education ac-
tivities the R25 CEGP supports, showcased the successes of
their respective programs. The in-depth discussion led to valu-
able suggestions to strengthen the R25 CEGP in meeting new
cancer education needs brought about by rapid progress in
cancer research, encouraging innovative educational ap-
proaches, improving R25 CEGP application preparation and
peer review, and employing more effective strategies for en-
hancing diversity. One gratifying outcome of the workshop
was that it brought together for the first time cancer educators
who conduct different forms of education activities in differ-
ent fields. The participants, including those who had engaged
in cancer education for several decades, were pleasantly sur-
prised that there were so many educators in the workshop
whom they did not previously know. The excitement of being
exposed to novel ideas and meeting new colleagues was evi-
dent at the gathering, and the workshop has already led to the
initiation of several collaborations. There was a clear consen-
sus that the NCI R25 CEGP offers a powerful platform for
developing a stronger cancer education community.
Continued efforts such as holding similar workshops period-
ically in the future will generate synergy among educators
currently in the community and help bring many more dedi-
cated educators into the community.
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